Novavax Inc (NVAX)
3.955
+0.06
(+1.54%)
USD |
NASDAQ |
Apr 19, 10:04
Novavax Cash from Operations (TTM): -713.97M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -713.97M |
| September 30, 2023 | -655.00M |
| June 30, 2023 | -654.06M |
| March 31, 2023 | -653.02M |
| December 31, 2022 | -415.94M |
| September 30, 2022 | -640.53M |
| June 30, 2022 | -743.96M |
| March 31, 2022 | -428.65M |
| December 31, 2021 | 322.95M |
| September 30, 2021 | 536.79M |
| June 30, 2021 | 672.43M |
| March 31, 2021 | 643.65M |
| December 31, 2020 | -42.54M |
| September 30, 2020 | 62.28M |
| June 30, 2020 | 36.52M |
| March 31, 2020 | -109.13M |
| December 31, 2019 | -136.62M |
| September 30, 2019 | -158.15M |
| June 30, 2019 | -159.40M |
| March 31, 2019 | -169.36M |
| December 31, 2018 | -184.82M |
| September 30, 2018 | -182.96M |
| June 30, 2018 | -193.62M |
| March 31, 2018 | -166.05M |
| December 31, 2017 | -144.48M |
| Date | Value |
|---|---|
| September 30, 2017 | -165.63M |
| June 30, 2017 | -183.80M |
| March 31, 2017 | -233.43M |
| December 31, 2016 | -258.77M |
| September 30, 2016 | -248.97M |
| June 30, 2016 | -215.14M |
| March 31, 2016 | -165.43M |
| December 31, 2015 | -126.09M |
| September 30, 2015 | -91.11M |
| June 30, 2015 | -78.45M |
| March 31, 2015 | -77.07M |
| December 31, 2014 | -67.01M |
| September 30, 2014 | -59.51M |
| June 30, 2014 | -58.52M |
| March 31, 2014 | -55.21M |
| December 31, 2013 | -45.36M |
| September 30, 2013 | -36.35M |
| June 30, 2013 | -26.10M |
| March 31, 2013 | -24.59M |
| December 31, 2012 | -18.23M |
| September 30, 2012 | -17.85M |
| June 30, 2012 | -16.54M |
| March 31, 2012 | -18.81M |
| December 31, 2011 | -23.63M |
| September 30, 2011 | -26.57M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-743.96M
Minimum
Jun 2022
672.43M
Maximum
Jun 2021
-170.33M
Average
-158.15M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
| Pfizer Inc | 8.70B |
| Moderna Inc | -3.118B |
| Agilent Technologies Inc | 1.961B |
| Align Technology Inc | 785.78M |
| Lexicon Pharmaceuticals Inc | -161.90M |